Skip to main content

Medable to Present at 42nd Annual J.P. Morgan Healthcare Conference

Medable Inc., the leading technology provider for modern clinical trials, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Wednesday, January 10, 2024, at 7:30 AM Pacific Time (10:30 AM Eastern Time).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240103843146/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

About Medable

Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our innovative AI-driven technology is transforming clinical trial evidence data collection, analysis, and application, resulting in increased speed and efficiency to bring life-saving therapies to patients faster. We are accelerating the generation of critical evidence by digitizing and connecting with patients at consumer scale. The flexibility of our technology has powered 300+ clinical trials, across 70+ countries, in 115+ languages, with over 1M patients having utilized our platform, ensuring broader, more diverse patient engagement. Medable is trusted by 14 of the top 20 pharmaceutical companies and 9 of the top 10 CROs. To date, we have secured $500M+ in funding from top-tier investors, including Blackstone, Sapphire, PPD/ThermoFisher, and GSR Ventures.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.